Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Transient memory impairment and hallucinations associated with tolterodine use.

× No keyword cloud information.

19 in total

Review 1. Safety and tolerability profiles of anticholinergic agents used for the treatment of overactive bladder.

Authors: Michael G Oefelein
Journal: Drug Saf Date: 2011-09-01 Impact factor: 5.606

2. Imidafenacin has no influence on learning in nucleus basalis of Meynert-lesioned rats.

Authors: Takanobu Yamazaki; Ayako Fukata
Journal: Naunyn Schmiedebergs Arch Pharmacol Date: 2013-08-31 Impact factor: 3.000

Review 3. Overactive bladder in the elderly: a guide to pharmacological management.

Authors: David R Staskin
Journal: Drugs Aging Date: 2005 Impact factor: 3.923

Review 4. The evaluation of rapidly progressive dementia.

Authors: Michael Henry Rosenbloom; Alireza Atri
Journal: Neurologist Date: 2011-03 Impact factor: 1.398

5. Dose response with darifenacin, a novel once-daily M3 selective receptor antagonist for the treatment of overactive bladder: results of a fixed dose study.

Authors: Simon Hill; Vik Khullar; Jean-Jacques Wyndaele; Karine Lheritier
Journal: Int Urogynecol J Pelvic Floor Dysfunct Date: 2005-07-06

Review 6. Anticholinergics for Overactive Bladder in Frail and Medically Complex Older People: The Case For.

Authors: Adrian Wagg
Journal: Drugs Aging Date: 2018-09 Impact factor: 3.923

Review 7. Blood-brain barrier permeation and efflux exclusion of anticholinergics used in the treatment of overactive bladder.

Authors: Michael B Chancellor; David R Staskin; Gary G Kay; Bobby W Sandage; Michael G Oefelein; Jack W Tsao
Journal: Drugs Aging Date: 2012-04-01 Impact factor: 3.923

8. Efficacy and tolerability of darifenacin, a muscarinic M3 selective receptor antagonist (M3 SRA), compared with oxybutynin in the treatment of patients with overactive bladder.

Authors: Norman Zinner; John Tuttle; Leonard Marks
Journal: World J Urol Date: 2005-11-08 Impact factor: 4.226

9. Medical management of overactive bladder.

Authors: Sarvpreet S Ubee; Ramaswamy Manikandan; Gurpreet Singh
Journal: Indian J Urol Date: 2010-04

10. Tolterodine extended release is well tolerated in older subjects.

Authors: T L Griebling; S R Kraus; H E Richter; D B Glasser; M Carlsson
Journal: Int J Clin Pract Date: 2009-08 Impact factor: 2.503